ConductScience.org, home

Paper8908701

Targeting of peripheral blood T lymphocytes.

Bolhuis RL and 2 others. Springer Semin Immunopathol, 1996. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Targeting of peripheral blood T lymphocytes. Papers, record 8908701. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8908701

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting of peripheral blood T lymphocytes.
PubMed
Journal
Springer Semin Immunopathol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2019-11-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bolhuis RLR L
2Hoogenboom HRH R
3Gratama JWJ W

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EpitopesMajor topic
Immunologic MemoryMajor topic
LeukocytesMajor topic
T-Lymphocytes, CytotoxicMajor topic
Animals
Humans

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11833054Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model.Cancer Res1991https://conductscience.org/library/papers/1833054PubMed
26347870Internal disintegration model of cytotoxic lymphocyte-induced target damage.Immunol Rev1983https://conductscience.org/library/papers/6347870PubMed
37527443CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells.J Immunol1994https://conductscience.org/library/papers/7527443PubMed
43108382Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice.J Immunol1987https://conductscience.org/library/papers/3108382PubMed
58187084Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma.Cancer Res1994https://conductscience.org/library/papers/8187084PubMed
62142014Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.Cancer Res1990https://conductscience.org/library/papers/2142014PubMed
71908075Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains.Nucleic Acids Res1991https://conductscience.org/library/papers/1908075PubMed
88496973Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2.J Natl Cancer Inst1993https://conductscience.org/library/papers/8496973PubMed
91760806T cell targeting in cancer therapy.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1760806PubMed
101737014Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli.Biochemistry1992https://conductscience.org/library/papers/1737014PubMed
111881921T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1881921PubMed
121748994By-passing immunization. Human antibodies from V-gene libraries displayed on phage.J Mol Biol1991https://conductscience.org/library/papers/1748994PubMed
137520535Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways.Nature1994https://conductscience.org/library/papers/7520535PubMed
143160953Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody.Nature1985https://conductscience.org/library/papers/3160953PubMed
151720808
CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
J Exp Med1991https://conductscience.org/library/papers/1720808PubMed
162513569Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2513569PubMed
178011287Making antibodies by phage display technology.Annu Rev Immunol1994https://conductscience.org/library/papers/8011287PubMed
183102250The use of hybrid hybridomas to target human cytotoxic T lymphocytes.Eur J Immunol1987https://conductscience.org/library/papers/3102250PubMed
197753171Serial triggering of many T-cell receptors by a few peptide-MHC complexes.Nature1995https://conductscience.org/library/papers/7753171PubMed
201910674A central role of perforin in cytolysis?Annu Rev Immunol1991https://conductscience.org/library/papers/1910674PubMed

See all 117 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
17579857A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.Cancer Immunol Immunother2008https://conductscience.org/library/papers/17579857PubMed
11599633Specific immunotherapy of cancer in elderly patients.Drugs Aging2001https://conductscience.org/library/papers/11599633PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8908701

GET https://conductscience.org/api/papers/v1/8908701/references?page=2